The phrase "agents for future" is not correct in standard written English.
It may be intended to refer to individuals or entities that act on behalf of future interests or outcomes, but it lacks clarity and grammatical structure.
Example: "We need to identify the agents for future development in our community."
Alternatives: "advocates for the future" or "representatives for future initiatives".
In summary, O-benzyl-substituted chalcones were identified as promising anti-HIV agents for future investigation.
This study also demonstrates that these rationally designed cationic and amphipathic helical AMPs exhibited high selectivity against several Vibrio spp. and are potential agents for future use in the treatment of these marine pathogens.
Because a greater understanding of the protein cisplatin interactions at the molecular level can inform the design of cisplatin-like agents for future use, mass spectrometric determination of the binding site of cisplatin on a model protein, cytochrome c, was undertaken in this paper.
This issue can certainly affect expectations of agents for future disturbances.
Both could be alternative antiproliferative agents for future development as anti-cancer drugs.
This review strives for compiling previous antiviral studies of algae-derived polysaccharides and their mechanism of action towards their development as natural antiviral agents for future investigations.
This study developed a new strategy of tissue engineered bulking agent for future ISD therapy.
Its efficacy, convenient dosing, and predictable safety profile make it an ideal agent for future study of these difficult-to-treat central nervous system malignancies.
In comparison with GO, RGO is known to have increased conductive and optical absorbance, making it a more attractive agent for future cancer photothermal therapy.
The current strategy of testing new targeted drugs as single agents is necessary, but should be regarded as the first step in evaluation of the agent for future combination with other agents.
Altogether, our optimized process resulting in high concentrations of target protein, namely rSAK-2, provides an excellent platform to initialize the downstream process development of this promising fibrinolyic agent for future clinical evaluation.
